Lancet 387 , 679690, (2016)
Improved blood pressure control in this population could contribute meaningfully to symptom relief and better long-term outcomes.25 Improvement in glycemic control was evident among diabetic subgroups treated with GLP-1RAs, aligning with their established role in lowering blood glucose.26 However, the high heterogeneity observed among the studies indicates that the magnitude of this effect may be compromised by variability in the baseline characteristics such as HbA1c levels, duration of diabetes, different GLP-1RAs and their doses used
The Wegovy manufacturer, Novo Nordisk, typically offers a savings program for private or commercial insurance patients to get affordable treatment
It's metabolic recalibration
GI discomfort, including diarrhea, nausea, and constipation, is the most common side effect and is usually caused by taking too much too soon or taking it on an empty stomach